Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Arne Van der Vreken actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Breaking T-cell resistance in Multiple Myeloma: Antygen discovery, escape mechanisms and metabolic cues for CAR T-cell therapy
Van der Vreken, A., 2026, 252 blz.Onderzoeksoutput: PhD Thesis
-
Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma
Tu, C., Van der Vreken, A., Meeus, F., van den Broecke, L., Brons, J., De Veirman, K., Vanderkerken, K., De Bruyne, E., Breckpot, K. & Menu, E., dec. 2026, In: Experimental Hematology and Oncology. 15, 1, 6 blz., 1.Onderzoeksoutput: Article › peer review
Open Access -
The clinically available supplement pyruvate enhances the therapeutic effect of bortezomib in Multiple Myeloma by modulating mitochondrial metabolism
Tu, C., Van der Vreken, A., Faict, S., Ates, G., Massie, A., De Veirman, K., De Bruyne, E., Vanderkerken, K. & Menu, E., 1 mrt. 2026, In: Cancer Letters. 640, 15 blz., 218245.Onderzoeksoutput: Article › peer review
-
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
van der Vreken, A., Meeus, F., Tu, C., van den Broecke, L., Raimondi, V., Vescovini, R., Hanssens, H., Watté, F., Autaers, D., Aragon, M., Billiau, J., De Veirman, K., Vanderkerken, K., De Vlaeminck, Y., Franceschini, L., Lee, H., Neri, P., De Bruyne, E., Storti, P. & Giuliani, N. & 2 anderen, , 14 nov. 2025, In: Journal of Hematology & Oncology. 18, 17 blz., 103.Onderzoeksoutput: Article › peer review
Open AccessBestand -
B7-H3 nanobody-based CAR T cells control Multiple Myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
Van der Vreken, A., 25 sep. 2025.Onderzoeksoutput: Poster
Datasets
-
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism
Menu, E. (Creator), Oudaert, I. (Creator), Vanderkerken, K. (Creator), De Veirman, K. (Creator), De Bruyne, E. (Creator), Van der Vreken, A. (Creator), Ates, G. (Creator), Massie, A. (Creator) & Maes, K. (Creator), DRYAD, 6 nov. 2025
Dataset
-
Syntenin inhibition impairs stroma-tumor communication in Multiple Myeloma and improves Bortezomib treatment efficiency
Tu, C. (Creator), Leblanc, R. (Creator), Van der Vreken, A. (Creator), Koops, M. (Creator), Audebert, S. (Creator), Goullieux, L. (Creator), Meeusen, S. (Creator), De Veirman, K. (Creator), De Bruyne, E. (Creator), Vanderkerken, K. (Creator), David, G. (Creator), Cupedo, T. (Creator), Zimmermann, P. (Creator) & Menu, E. (Creator), Proteomics Identifications Database (PRIDE), 26 jul. 2025
https://www.ebi.ac.uk/pride/archive/projects/PXD064458
Dataset
-
Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma
Menu, E. (Creator), Van der Vreken, A. (Creator), Tu, C. (Creator), De Bruyne, E. (Creator), van den Broecke, L. (Creator), Meeus, F. (Creator), Brons, J. (Creator), De Veirman, K. (Creator), Vanderkerken, K. (Creator) & Breckpot, K. (Creator), Gene Expression Omnibus (GEO), 11 sep. 2025
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307311
Dataset
Prijzen
-
-
FWO Grant for a long stay abroad
Van der Vreken, A. (Recipient), 13 mrt. 2024
Prijs: Other distinction
-
FWO travelgrant
Van der Vreken, A. (Recipient) & Menu, E. (Recipient), 7 feb. 2024
Prijs: Other distinction
Activiteiten
-
IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of Multiple Myeloma
Satilmis, H. (Speaker), Denis, A. (Contributor), Verheye, E. (Contributor), Van der Vreken, A. (Contributor), Zhan, D. (Contributor), Calliauw, E. (Contributor), Törngren, M. (Contributor), Eriksson, H. (Contributor), Faict, S. (Contributor), De Bruyne, E. (Contributor), Menu, E. (Contributor), Vanderkerken, K. (Contributor) & De Veirman, K. (Contributor)
6 feb. 2026Activiteit: Talk or presentation at a conference
-
B7-H3 nanobody-based CAR T cells control Multiple Myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
Van der Vreken, A. (Speaker)
25 sep. 2025Activiteit: Talk or presentation at a conference
-
Unveiling B7-H3 as novel target for CAR T-cell therapy in Multiple Myeloma
Van der Vreken, A. (Speaker) & Menu, E. (Contributor)
2 feb. 2024Activiteit: Talk or presentation at a conference
-
Long research stay abroad: University of Parma (Italy)
Van der Vreken, A. (Organiser)
1 mei 2024 → 30 jun. 2024Activiteit: Research and Teaching at External Organisation